|
LOC400927 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.275280E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.277600E-03 |
| Normal-vs-Stage2 |
7.514000E-02 |
| Normal-vs-Stage3 |
1.030100E-04 |
| Normal-vs-Stage4 |
3.823600E-03 |
| Stage1-vs-Stage2 |
9.285000E-01 |
| Stage1-vs-Stage3 |
6.369900E-02 |
| Stage1-vs-Stage4 |
3.329200E-01 |
| Stage2-vs-Stage3 |
2.474600E-01 |
| Stage2-vs-Stage4 |
4.505600E-01 |
| Stage3-vs-Stage4 |
6.802200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.422600E-04 |
| Normal-vs-AfricanAmerican |
2.883600E-01 |
| Normal-vs-Asian |
1.670430E-01 |
| Caucasian-vs-AfricanAmerican |
2.654200E-01 |
| Caucasian-vs-Asian |
1.964630E-01 |
| AfricanAmerican-vs-Asian |
9.179800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.916200E-03 |
| Normal-vs-Female |
1.223890E-03 |
| Male-vs-Female |
5.875600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.009590E-02 |
| Normal-vs-Age(41-60Yrs) |
3.658800E-03 |
| Normal-vs-Age(61-80Yrs) |
9.427000E-04 |
| Normal-vs-Age(81-100Yrs) |
7.577800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.077200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.383000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.842400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.702200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.164400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.399800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.2721999999975E-05 |
| Classical-VS-Follicular |
1.030030E-01 |
| Classical-VS-Other |
5.013800E-01 |
| Classical-VS-Normal |
2.195300E-03 |
| Tall-VS-Follicular |
1.72149999999593E-06 |
| Tall-VS-Other |
3.800900E-03 |
| Tall-VS-Normal |
5.50450000025293E-08 |
| Follicular-VS-Other |
9.106600E-01 |
| Follicular-VS-Normal |
1.469390E-01 |
| Other-VS-Normal |
5.632400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.542100E-03 |
| Normal-vs-N1 |
4.621600E-01 |
| N0-vs-N1 |
1.780810E-01 |
|
|
